Ewan Cobran, an assistant professor of clinical and administrative pharmacy in the College of Pharmacy, received $40,000 from the American Cancer Society to study some of the health effects of Androgen Deprivation Therapy and whether these conditions vary by race and ethnicity for males with advanced prostate cancer.
Cobran’s research directly addresses the burdens of racial disparities in prostate cancer outcomes by evaluating whether minority males are at higher risk of treatment-related co-morbidities—including the development of diabetes, myocardial infarction and cardiovascular diseases—and how these complications affect survival rates.
